AssetMark’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.69K Hold
177
– – ﹤0.01% 3093
2026
Q2
$1.4K Buy
+177
New +$1.13K ﹤0.01% 3075

Other funds holding XERS

AssetMark's XERS Position: Q3 2026 in Review

AssetMark held its Xeris Biopharma Holdings (XERS) position steady in Q3 2026 at 177 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3093.

AssetMark first reported a position in XERS in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • AssetMark held 177 shares of Xeris Biopharma Holdings worth $1.69K as of Q3 2026.
  • AssetMark left its Xeris Biopharma Holdings share count unchanged in Q3 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3093 holding.
  • AssetMark first reported a position in Xeris Biopharma Holdings in Q2 2026 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.